CIAOMed Roundtable: Lupus Experts Predict More Use of RA Drugs, Seek Biomarkers to Speed Clinical Trials

CIAOMed's "Virtual Roundtable" of lupus experts identified drugs borrowed from other areas of rheumatology as the most important recent advances in treatment of systemic lupus erythematosus (SLE) and emphasized the need for reliable biomarkers as the major rate-limiting factor in SLE clinical research.

Read full article